Science 37 Holdings Inc (SNCE) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Science 37 Holdings Inc   (NASDAQ: SNCE)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Science 37 Holdings Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Science 37 Holdings Inc's ROI in the third quarter of 2023?
Science 37 Holdings Inc recorded a cumulative net loss of $-111 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -143.77%.

Within the Healthcare sector 12 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 0 to 54.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -54.26 % -19.54 % 45.79 % 231.76 % 553.91 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 58 68 84 98 166
Return On Investment (TTM) -143.77 % -128.85 % -95.61 % -7.41 % -184.44 %
SNCE's Overall Ranking # 54 # 0 # 0 # 0 #
Seq. Investment Change TTM -26.08 % -21.15 % -17.88 % -4.43 % 30.01 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -111 -134 -126 -12 -311

SNCE Company Profile >> Back to SNCE Roi Comparisons >> See Annual SNCE Return On Investment



Return On Investment SNCE's Ranking
Within: No.
Industry # 0
Sector # 13
Overall # 54

Return On Investment Statistics
High Average Low
80.3 %
46.31 %
-1.03 %
(Mar 31 2022)   (Sep 30 2021)



  News about Science 37 Holdings Inc Return on Investment ROI

Catalyzing Next-Generation Clinical Research: Science 37's Revolution in North Carolina's Research Triangle Park

August 6, 2024

Science 37 Reinforces Clinical Trial Innovations with Cutting-Edge Research Facility in North Carolina s Research Triangle Park
In a groundbreaking move for the clinical research industry, Science 37 has unveiled its new corporate headquarters in Research Triangle Park, North Carolina. This state-of-the-art facility aims to revolutionize the way clinical trials are conducted by enhancing collaboration among stakeholders and improving patient recruitment and study support. With its commitment to combining technology and science, Science 37 is poised to reshape the landscape of clinical research, ultimately benefiting patients worldwide.
The Research Triangle Park, known as RTP, is a globally recognized hub for scientific innovation and research. With an extraordinary concentration of pharmaceutical, biotechnology, and medical device companies, RTP offers an ideal environment for Science 37 to establish its new headquarters. This move demonstrates Science 37 s dedication to being at the forefront of the industry by tapping into the rich resources and talent pool available in the region.

The Remarkable Success Story of Science 37: Fast Enrollment Rates and Impressive ROI

July 18, 2024


In the competitive world of clinical trials and healthcare research, one company has emerged as a standout performer. Science 37 Holdings Inc, a leader in decentralized clinical trials, has recently achieved some remarkable milestones that have caught the attention of both industry experts and investors.
Firstly, Science 37 proudly announced that it successfully enrolled 42% of the trial cohort in just 8 weeks. This impressive feat highlights the company s ability to swiftly recruit participants for clinical trials, which is crucial for the timely completion of research studies. Furthermore, Science 37 has been consistently enrolling an average of 65 patients per month for its sponsor s Phase 3 infectious disease clinical trial. These rapid enrollment rates demonstrate Science 37 s efficiency and expertise in conducting trials.





Financial Statements
Science 37 Holdings Inc's III. Quarter Investments $ 58 Millions SNCE's Balance sheet
Science 37 Holdings Inc's III. Quarter Income $ 0 Millions Quarterly SNCE's Income Statement
SNCE's Income by Division See SNCE's Income by Division


SNCE Annual Return On Investment (Dec 31 2022)
2022		 (Jun 30 2021)
2021


Total Investments in Millions 98 81 0 0 0
Y / Y Investment Growth 21.9 % - - - -
Net Income in Millions 0 -1 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.09 % -0.7 % - - -


Annual Roi Comment
In the fiscal year 2022 ROI improved to 0.09 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SNCE's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SNCE's Competitors
Subscribers only: Roi for Science 37 Holdings Inc's Suppliers
Subscribers only: Return On Investment for SNCE's Customers

Other Ratios
SNCE's Roa SNCE's Inventory Turnover Ratio SNCE's Growth Rates SNCE's Dividend Statistics
SNCE's Profitability Ratios SNCE's Asset Turnover Ratio SNCE's Dividend Growth
SNCE's Roe SNCE's Valuation Ratios SNCE's Financial Strength Ratios SNCE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.